BenzingaWed, 11 Mar 2026 18:19:40 GMTRegenxbio Reports Duchenne Gene Therapy Progress As Stock Slides On Mixed SignalsRGNX-1.95%
Seeking AlphaThu, 05 Mar 2026 22:45:57 GMTREGENXBIO Inc. (RGNX) Q4 2025 Earnings Call TranscriptRGNX-1.95%
Zacks Investment ResearchThu, 05 Mar 2026 14:25:39 GMTRegenxbio (RGNX) Reports Q4 Loss, Lags Revenue EstimatesRGNX-1.95%
Zacks Investment ResearchThu, 26 Feb 2026 16:01:26 GMTRegenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?RGNX-1.95%